Treatment of choice for stage I non-small cell lung cancer: Surgery or radiotherapy?

Journal of Thoracic Oncology

Volumn 1, Issue 8, 2006, Pages 766-767

  Asamura, Hisao ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; FOLLOW UP; HUMAN; INOPERABLE CANCER; INTERMETHOD COMPARISON; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDIASTINUM METASTASIS; OVERALL SURVIVAL; PATIENT ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURGEON; SURGICAL PATIENT; TUMOR VOLUME; LUNG TUMOR; MORTALITY; RADIOSURGERY; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; RADIOSURGERY; SURVIVAL RATE;

EID: 34248350047     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200610000-00002     Document Type: Editorial

References (9)

1. Ginsberg RJ, Goldberg M, Waters PF. Surgery for non-small cell lung cancer. In Roth JA, Ruckdeschel JC, Weisenburger TH (Eds.), Thoracic Oncology, 2nd ed. Philadelphia: W.B. Saunders, 1995, pp 124-146.
2. Goya T, Asamura H, Yoshimura H, et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: A Japanese lung cancer registry study. Lung Cancer 2006;50:227-234.
3. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 2006;80:2051-2056.
4. Watanabe S, Asamura H, Suzuki K, Tsuchiya R. Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg 2004;78:999-1003.
5. Straus GM, Herndon JE, Maddaus MA, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer and Leukemia Group B (CALGB) protocol 9633. Proc Ann Meet Am Assoc Cancer Res 2006;24:7007.
6. Graham P, Vinod SK, Hui AC. Stage I non-small cell lung cancer: results for surgery in a patterns of care study in Sydney and also for high dose concurrent end-phase boost accelerated radiotherapy. J Thorac Oncol 2006;1:771-779.
7. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractonated highdose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-1631.
8. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation (LACE): a pooled analysis of five randomized clinical trials including 4,584 patients. Proc Ann Meet Am Assoc Cancer Res 2006;24:7008.
9. Allen MS, Darling GE, Pechet TTV, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-1020.